Sandoz-irbesartan/hct Product Recall (2021-05-27)
Sandoz Irbesartan/HCT Recall Summary Sandoz is recalling irbesartan/hydrochlorothiazide (HCT) medications across Canada due to a product safety issue. This recall affects people taking this blood pressure medication. The recall is classified as Class I, meaning there is a serious potential health risk associated with the affected product.
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2021-05-27
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/d9c3f6ca-bf60-4cd1-9b8b-b304df744198